Getzenberg RH - Search Results

1

Highly specific urine-based marker of bladder cancer.

Van Le TS, Miller R, Barder T, Babjuk M, Potter DM, Getzenberg RH. Van Le TS, et al. Among authors: getzenberg rh. Urology. 2005 Dec;66(6):1256-60. doi: 10.1016/j.urology.2005.07.010. Urology. 2005. Retraction in: Urology. 2014 Jun;83(6):1448. doi: 10.1016/j.urology.2014.04.001. PMID: 16360453 Retracted.

2

Functional characterization of the bladder cancer marker, BLCA-4.

Van Le TS, Myers J, Konety BR, Barder T, Getzenberg RH. Van Le TS, et al. Among authors: getzenberg rh. Clin Cancer Res. 2004 Feb 15;10(4):1384-91. doi: 10.1158/1078-0432.ccr-0455-03. Clin Cancer Res. 2004. Retraction in: Clin Cancer Res. 2013 Jun 15;19(12):3327. doi: 10.1158/1078-0432.CCR-13-1145. PMID: 14977841 Retracted.

3

Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology.

Myers-Irvin JM, Van Le TS, Getzenberg RH. Myers-Irvin JM, et al. Among authors: getzenberg rh. Cancer Res. 2005 Aug 15;65(16):7145-50. doi: 10.1158/0008-5472.CAN-05-1142. Cancer Res. 2005. Retraction in: Cancer Res. 2014 Feb 1;74(3):974. doi: 10.1158/0008-5472.CAN-13-3721. PMID: 16103064 Retracted.

4

Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer.

Konety BR, Nguyen TS, Brenes G, Sholder A, Lewis N, Bastacky S, Potter DM, Getzenberg RH. Konety BR, et al. Among authors: getzenberg rh. J Urol. 2000 Sep;164(3 Pt 1):634-9. doi: 10.1097/00005392-200009010-00004. J Urol. 2000. PMID: 10953114

5

Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma.

Babjuk M, Soukup V, Pesl M, Kostírová M, Drncová E, Smolová H, Szakacsová M, Getzenberg R, Pavlík I, Dvorácek J. Babjuk M, et al. Urology. 2008 Apr;71(4):718-22. doi: 10.1016/j.urology.2007.12.021. Urology. 2008. PMID: 18387400 Clinical Trial.

6

Use of the novel marker BLCA-1 for the detection of bladder cancer.

Myers-Irvin JM, Landsittel D, Getzenberg RH. Myers-Irvin JM, et al. Among authors: getzenberg rh. J Urol. 2005 Jul;174(1):64-8. doi: 10.1097/01.ju.0000162022.36772.a4. J Urol. 2005. PMID: 15947579

7

Use of urine-based markers for detection and monitoring of bladder cancer.

Pirtskalaishvili G, Getzenberg RH, Konety BR. Pirtskalaishvili G, et al. Among authors: getzenberg rh. Tech Urol. 1999 Dec;5(4):179-84. Tech Urol. 1999. PMID: 10591254 Review.

8

Contribution of the prostate limits the usefulness of survivin for the detection of bladder cancer.

Davies B, Chen J, Modugno F, Weissfeld J, Landsittel D, Dhir R, Nelson J, Getzenberg RH. Davies B, et al. Among authors: getzenberg rh. J Urol. 2005 Nov;174(5):1767-70. doi: 10.1097/01.ju.0000177070.13987.ce. J Urol. 2005. PMID: 16217280

9

Efficacy of BTA stat, cytology, and survivin in bladder cancer surveillance over 5 years in patients with spinal cord injury.

Davies B, Chen JJ, McMurry T, Landsittel D, Lewis N, Brenes G, Getzenberg RH. Davies B, et al. Among authors: getzenberg rh. Urology. 2005 Oct;66(4):908-11. doi: 10.1016/j.urology.2005.05.022. Urology. 2005. PMID: 16230180

10

Urine based markers of urological malignancy.

Konety BR, Getzenberg RH. Konety BR, et al. Among authors: getzenberg rh. J Urol. 2001 Feb;165(2):600-11. doi: 10.1097/00005392-200102000-00081. J Urol. 2001. PMID: 11176445 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters